Glenmark Life Sciences

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue600.73574.49539.73594.11515.41
Expenses441.81413.82410.05443.87387.95
EBITDA172.45174.25144.57164.98142.89
EBIT159.33161.07130.04150.59127.80
Profit Before Tax158.93160.69129.68150.24127.46
Net Profit118.74118.7797.94111.4895.32
Financial Ratios
Operating Profit Margin28.97%30.42%26.94%28.03%28.19%
Net Profit Margin19.94%20.73%18.25%18.94%18.81%
Earning Per Share (Diluted)9.699.677.979.087.75
Dividends Per Share22.500.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ